FL-116

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameFL-116
Drug Alias NameFL-116FL116
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-PD-1Interleukin 18 receptor agonists
TargetsProgrammed cell death protein 1Interleukin 18 receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Forlongbiotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Forlongbiotech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A